EverQuote officer proposes $485K stock sale

The proposed shares include 11,406 from an option exercise and two RSU entries; the notice also lists separate sales earlier in the prior three months.

Available on EDGAR 10/30/2026 - 04:13 PM EDT Accepted by SEC EDGAR 10/30/2026 - 04:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

EverQuote, Inc. officer Jayme Mendal reported a proposed sale of 20,981 Class A common shares, with an approximate sale date of November 2, 2026, through Nasdaq. UBS Financial Services, Inc. is named as broker; the listed aggregate market value is $484,520.56. The listed shares include 11,406 from a stock-option exercise and RSU entries of 9,076 and 499 shares.

Key Figures

Shares in proposed sale: 20,981 shares Aggregate market value: $484,520.56 Shares sold: 20,981 shares +3 more

6 metrics

Shares in proposed sale 20,981 shares Approximate sale date November 2, 2026

Aggregate market value $484,520.56 Proposed sale

Shares sold 20,981 shares September 15, 2026

Sale proceeds $509,123.97 September 15, 2026

Shares sold 20,980 shares October 1, 2026

Sale proceeds $413,098.21 October 1, 2026

Key Terms

Rule 144, RSU, Exercise of Stock Options

3 terms

Rule 144 regulatory

"sales ... required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU financial

"Class A Common | 02/25/2025 | RSU"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

Exercise of Stock Options financial

"11/02/2026 | Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What prior sales does EVER officer Jayme Mendal report?

Jayme Mendal's reported sales in the preceding three months were 20,981 Class A common shares on September 15, 2026, for $509,123.97, and 20,980 shares on October 1, 2026, for $413,098.21.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001744403
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EverQuote, Inc.
SEC File Number	001-38549
Address of Issuer	141 PORTLAND STREET CAMBRIDGE MASSACHUSETTS 02139
Phone	617-245-0615
Name of Person for Whose Account the Securities are To Be Sold	Mendal Jayme
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	20981	484520.56	31682105	11/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	11/02/2026	Exercise of Stock Options	Issuer			11406	11/02/2026	Cash
Class A Common	02/25/2025	RSU	Issuer			9076	02/25/2025	N/A
Class A Common	05/25/2025	RSU	Issuer			499	05/25/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jayme Mendal c/o 141 PORTLAND STREET Cambridge MA 02139	Class A Common	09/15/2026	20981	509123.97
Jayme Mendal c/o 141 PORTLAND STREET Cambridge MA 02139	Class A Common	10/01/2026	20980	413098.21

144: Remarks and Signature

Remarks
Date of Notice	10/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Jayme Mendal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)